| Ytd | -16.31% | |
| 1y | -69.07% |
| Open | 5.28 | Prev Close | 5.79 | Low | 5.28 | High | 5.76 | Mkt Cap | 2.98M |
| Vol | 24.91K | Avg Vol | 18.31K | EPS | -14.93 | P/E | -0.37 | Forward P/E | -0.45 |
| Beta | 0.54 | Short Ratio | 9.07 | Inst. Own | 14.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 5.69 | 200-d Avg | 9.06 | 1yr Est | 9.00 |
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the pr
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.17) per share which missed the analyst consens
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage
On Wednesday, 329 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report